Form 4: Incyte Corp Director Edmund Harrigan Acquires Shares in Rule 10b5-1 Transaction

Director Edmund Harrigan acquired 413 shares of Incyte Corp common stock at $56.97 per share under a Rule 10b5-1 plan, while holding 13,115 shares after the transaction.

Summary

• On March 28, 2024, Edmund Harrigan, a director of Incyte Corp, acquired 413 shares of common stock at a price of $56.97 per share.
• The acquisition was made under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees, pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.
• Following the transaction, Harrigan beneficially owns 13,115 shares of Incyte Corp common stock.
• This total includes 2,505 shares issuable pursuant to previously reported restricted stock units that have not vested.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine transaction under a pre-arranged plan. The director's stock acquisition could be seen as a slightly positive sign, but it's not a major event.

Positives

• The acquisition of shares by a director can be seen as a positive signal, indicating confidence in the company's future prospects.
• The use of a pre-arranged Rule 10b5-1 trading plan suggests that the transaction was planned and not based on any inside information.

Future Outlook

There is no specific future outlook provided in this document.

Industry Context

This filing is a routine disclosure of a transaction by a company insider. It is common for directors to receive stock as part of their compensation and to use Rule 10b5-1 plans to manage their trading activity. It is important to monitor insider transactions as they can provide insights into management's view of the company's prospects.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment, as it signals confidence from a company director.

Key Dates